4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $20.45M in the twelve months ending March 31, 2024, with 826.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $28.00K, a -90.60% decrease year-over-year. In the year 2023, 4D Molecular Therapeutics had annual revenue of $20.72M with 562.29% growth.

• Revenue (ttm): $20.45M
• Revenue Growth: +826.69%
• P/S Ratio: 63.91
• Revenue / Employee: $139,129
• Employees: 147
• Market Cap: 1.31B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.